Advertisement

Obesity, Fatty Liver and Liver Cancer

  • Jun Yu

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1061)

Table of contents

About this book

Introduction

This volume covers a state-of-the-art illustration of recent discoveries concerning obesity-related fatty liver diseases and liver cancer. The contents are extensive and comprehensive. It brings important topics in the field all together under one umbrella, from epidemiology and etiology, molecular pathogenesis, cellular biology, epigenetics, immunology, microbiology, animal models to therapeutic approaches and treatments. All the book contributors are leading experts in the field. It will appeal to researchers, clinicians and graduate students in obesity, fatty liver diseases, GI/Liver cancer field. It may also yield benefits for pharmaceutical companies with regard to drug discovery.

Keywords

non-alcoholic fatty liver disease (NAFLD) non-alcoholic steatohepatitis (NASH) hepatocellular carcinoma (HCC) obesity Liver cancer GI cancer Liver fibrosis

Editors and affiliations

  • Jun Yu
    • 1
  1. 1.Institute of Digestive Disease and Department of Medicine & Therapeutics State Key Laboratory of Digestive Disease LKS Institute of Health SciencesThe Chinese University of Hong KongHong KongHong Kong

Bibliographic information

  • DOI https://doi.org/10.1007/978-981-10-8684-7
  • Copyright Information Springer Nature Singapore Pte Ltd. 2018
  • Publisher Name Springer, Singapore
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-981-10-8683-0
  • Online ISBN 978-981-10-8684-7
  • Series Print ISSN 0065-2598
  • Series Online ISSN 2214-8019
  • Buy this book on publisher's site
Industry Sectors
Pharma
Biotechnology
Consumer Packaged Goods